Showing results (51-60 of 322) with videos related to

Sort By:
Pageof 33
Cells|August 27, 2021
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative NeoplasmsGiuseppe G Loscocco, Giacomo Coltro, Paola Guglielmelli, et al.
Blood|June 25, 2009
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allelePaola Guglielmelli, Giovanni Barosi, Giorgina Specchia, et al.
American Journal of Hematology|September 3, 2013
Masked polycythemia vera (mPV): results of an international studyTiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.
Blood Cancer Journal|February 27, 2020
The new WHO classification for essential thrombocythemia calls for revision of available evidencesTiziano Barbui, Jürgen Thiele, Alberto Ferrari, et al.
Journal of Cellular and Molecular Medicine|June 16, 2009
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectivesAlessandro M Vannucchi, Paola Guglielmelli, Alessandro Rambaldi, et al.
Annals of the New York Academy of Sciences|June 17, 2005
Role of GATA-1 in normal and neoplastic hemopoiesisAnna Rita Migliaccio, Rosa Alba Rana, Alessandro M Vannucchi, et al.
Expert Review of Molecular Diagnostics|October 11, 2025
Mutation profiling of chronic myeloproliferative neoplasms: improving clinical-molecular prognostic modelsGiuseppe G Loscocco, Naseema Gangat, Paola Guglielmelli, et al.
Annals of the New York Academy of Sciences|May 1, 2007
Role of thrombopoietin in mast cell differentiationAnna Rita Migliaccio, Rosa Alba Rana, Alessandro M Vannucchi, et al.
Seminars in Oncology|October 6, 2005
Pathogenesis of myelofibrosis with myeloid metaplasia: lessons from mouse models of the diseaseAlessandro M Vannucchi, Anna Rita Migliaccio, Francesco Paoletti, et al.
Pageof 33